Tüttenberg J - Search Results

1

Study protocol for a prospective, randomized, multicenter trial to investigate the influence of peripheral nerve stimulation on patients with chronic sacroiliac joint syndrome (SILENCING).

Sargut TA, Tkatschenko D, Früh A, Tüttenberg J, Heckert A, Fleck S, Kuckuck A, Bayerl SH. Sargut TA, et al. Among authors: tuttenberg j. Trials. 2024 Mar 28;25(1):223. doi: 10.1186/s13063-024-08067-z. Trials. 2024. PMID: 38549128 Free PMC article.

2

Correction: CD95 maintains stem cell-like and non-classical EMT programs in primary human glioblastoma cells.

Drachsler M, Kleber S, Mateos A, Volk K, Mohr N, Chen S, Cirovic B, Tüttenberg J, Gieffers C, Sykora J, Wirtz C, Mueller W, Synowitz M, Martin-Villalba A. Drachsler M, et al. Among authors: tuttenberg j. Cell Death Dis. 2020 Jul 22;11(7):558. doi: 10.1038/s41419-020-2698-3. Cell Death Dis. 2020. PMID: 32699236 Free PMC article.

3

Erratum to: COXIBRAIN: results of the prospective, randomised, phase II/III study for the selective COX-2 inhibition in chronic subdural haematoma patients.

Schaumann A, Klene W, Rosenstengel C, Ringel F, Tüttenberg J, Vajkoczy P. Schaumann A, et al. Among authors: tuttenberg j. Acta Neurochir (Wien). 2017 Jan;159(1):13. doi: 10.1007/s00701-016-3016-9. Acta Neurochir (Wien). 2017. PMID: 27830324 No abstract available.

4

COXIBRAIN: results of the prospective, randomised, phase II/III study for the selective COX-2 inhibition in chronic subdural haematoma patients.

Schaumann A, Klene W, Rosenstengel C, Ringel F, Tüttenberg J, Vajkoczy P. Schaumann A, et al. Among authors: tuttenberg j. Acta Neurochir (Wien). 2016 Nov;158(11):2039-2044. doi: 10.1007/s00701-016-2949-3. Epub 2016 Sep 7. Acta Neurochir (Wien). 2016. PMID: 27605230 Clinical Trial.

5

CD95 maintains stem cell-like and non-classical EMT programs in primary human glioblastoma cells.

Drachsler M, Kleber S, Mateos A, Volk K, Mohr N, Chen S, Cirovic B, Tüttenberg J, Gieffers C, Sykora J, Wirtz CR, Mueller W, Synowitz M, Martin-Villalba A. Drachsler M, et al. Among authors: tuttenberg j. Cell Death Dis. 2016 Apr 28;7(4):e2209. doi: 10.1038/cddis.2016.102. Cell Death Dis. 2016. PMID: 27124583 Free PMC article.

6

Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial.

Herrlinger U, Schäfer N, Steinbach JP, Weyerbrock A, Hau P, Goldbrunner R, Friedrich F, Rohde V, Ringel F, Schlegel U, Sabel M, Ronellenfitsch MW, Uhl M, Maciaczyk J, Grau S, Schnell O, Hänel M, Krex D, Vajkoczy P, Gerlach R, Kortmann RD, Mehdorn M, Tüttenberg J, Mayer-Steinacker R, Fietkau R, Brehmer S, Mack F, Stuplich M, Kebir S, Kohnen R, Dunkl E, Leutgeb B, Proescholdt M, Pietsch T, Urbach H, Belka C, Stummer W, Glas M. Herrlinger U, et al. Among authors: tuttenberg j. J Clin Oncol. 2016 May 10;34(14):1611-9. doi: 10.1200/JCO.2015.63.4691. Epub 2016 Mar 14. J Clin Oncol. 2016. PMID: 26976423 Clinical Trial.

7

Treatment monitoring in gliomas: comparison of dynamic susceptibility-weighted contrast-enhanced and spectroscopic MRI techniques for identifying treatment failure.

Vöglein J, Tüttenberg J, Weimer M, Gerigk L, Kauczor HU, Essig M, Weber MA. Vöglein J, et al. Among authors: tuttenberg j. Invest Radiol. 2011 Jun;46(6):390-400. doi: 10.1097/RLI.0b013e31820e1511. Invest Radiol. 2011. PMID: 21285888 Clinical Trial.

8

Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?

Weber MA, Henze M, Tüttenberg J, Stieltjes B, Meissner M, Zimmer F, Burkholder I, Kroll A, Combs SE, Vogt-Schaden M, Giesel FL, Zoubaa S, Haberkorn U, Kauczor HU, Essig M. Weber MA, et al. Among authors: tuttenberg j. Invest Radiol. 2010 Dec;45(12):755-68. doi: 10.1097/RLI.0b013e3181ec9db0. Invest Radiol. 2010. PMID: 20829706

9

Computed tomographic angiography: diagnostic procedure of choice in the management of subarachnoid hemorrhage in the elderly patient?

Pechlivanis I, Harders A, Tuttenberg J, Barth M, Schulte-Altedorneburg G, Schmieder K. Pechlivanis I, et al. Among authors: tuttenberg j. Cerebrovasc Dis. 2009;28(5):481-9. doi: 10.1159/000236526. Epub 2009 Sep 10. Cerebrovasc Dis. 2009. PMID: 19752549

10

Human brain tumor imaging with a protein-binding MR contrast agent: initial experience.

Essig M, Rohrer M, Giesel F, Tüttenberg J, Weber MA, Michaely H, Gerigk L, Voth M. Essig M, et al. Among authors: tuttenberg j. Eur Radiol. 2010 Jan;20(1):218-26. doi: 10.1007/s00330-009-1530-3. Epub 2009 Aug 12. Eur Radiol. 2010. PMID: 19672603 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters